Rosetta Ligand Docking with Flexible XML Protocols

Part of the Methods in Molecular Biology book series (MIMB, volume 819)


RosettaLigand is premiere software for predicting how a protein and a small molecule interact. Benchmark studies demonstrate that 70% of the top scoring RosettaLigand predicted interfaces are within 2Å RMSD from the crystal structure [1]. The latest release of Rosetta ligand software includes many new features, such as (1) docking of multiple ligands simultaneously, (2) representing ligands as fragments for greater flexibility, (3) redesign of the interface during docking, and (4) an XML script based interface that gives the user full control of the ligand docking protocol.

Key words

Rosetta RosettaLigand Ligand Docking Small molecule Flexible Flexibility Interface 


  1. 1.
    Meiler, J., and Baker, D. (2006) ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility, Proteins 65, 538–548.PubMedCrossRefGoogle Scholar
  2. 2.
    Kaufmann, K. W., Lemmon, G. H., Deluca, S. L., Sheehan, J. H., and Meiler, J. (2010) Practically useful: what the Rosetta protein modeling suite can do for you, Biochemistry 49, 2987–2998.PubMedCrossRefGoogle Scholar
  3. 3.
    Raman, S., Vernon, R., Thompson, J., Tyka, M., Sadreyev, R., Pei, J. M., Kim, D., Kellogg, E., DiMaio, F., Lange, O., Kinch, L., Sheffler, W., Kim, B. H., Das, R., Grishin, N. V., and Baker, D. (2009) Structure prediction for CASP8 with all-atom refinement using Rosetta, Proteins-Structure Function and Bioinformatics 77, 89–99.CrossRefGoogle Scholar
  4. 4.
    Chaudhury, S., and Gray, J. J. (2008) Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles, J Mol Biol 381, 1068–1087.PubMedCrossRefGoogle Scholar
  5. 5.
    Jiang, L., Althoff, E. A., Clemente, F. R., Doyle, L., Rothlisberger, D., Zanghellini, A., Gallaher, J. L., Betker, J. L., Tanaka, F., Barbas, C. F., Hilvert, D., Houk, K. N., Stoddard, B. L., and Baker, D. (2008) De novo computational design of retro-aldol enzymes, Science 319, 1387–1391.PubMedCrossRefGoogle Scholar
  6. 6.
    Davis, I. W., and Baker, D. (2009) RosettaLigand docking with full ligand and receptor flexibility, J Mol Biol 385, 381–392.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaufmann, K. W., Glab, K., Mueller, R., and Meiler, J. (2008) Small Molecule Rotamers Enable Simultaneous Optimization of Small Molecule and Protein Degrees of Freedom in ROSETTALIGAND Docking, In German Conference on Bioinformatics (Beyer, A., and Schroeder, M., Eds.), pp 148–157, Dresden.Google Scholar
  8. 8.
    Davis, I. W., Raha, K., Head, M. S., and Baker, D. (2009) Blind docking of pharmaceutically relevant compounds using RosettaLigand, Protein Sci 18, 1998–2002.PubMedCrossRefGoogle Scholar
  9. 9.
    Kaufmann, K. W., Dawson, E. S., Henry, L. K., Field, J. R., Blakely, R. D., and Meiler, J. (2009) Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies, Proteins 74, 630–642.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of ChemistryVanderbilt UniversityNashvilleUSA

Personalised recommendations